Literature DB >> 26218069

Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant.

Heather A Carey1, Agnieszka Bronisz2, Jennifer Cabrera1, Blake E Hildreth1,3, Maria Cuitiño1, Qi Fu1, Asrar Ahmad1, Ramiro E Toribio3, Michael C Ostrowski1, Sudarshana M Sharma1.   

Abstract

The Microphthalmia-associated transcription factor (MITF) is a basic helix-loop-helix leucine zipper family factor that is essential for terminal osteoclast differentiation. Previous work demonstrates that phosphorylation of MITF by p38 MAPK downstream of Receptor Activator of NFkB Ligand (RANKL) signaling is necessary for MITF activation in osteoclasts. The spontaneous Mitf cloudy eyed (ce) allele results in production of a truncated MITF protein that lacks the leucine zipper and C-terminal end. Here we show that the Mitf(ce) allele leads to a dense bone phenotype in neonatal mice due to defective osteoclast differentiation. In response to RANKL stimulation, in vitro osteoclast differentiation was impaired in myeloid precursors derived from neonatal or adult Mitf(ce/ce) mice. The loss of the leucine zipper domain in Mitf(ce/ce) mice does not interfere with the recruitment of MITF/PU.1 complexes to target promoters. Further, we have mapped the p38 MAPK docking site within the region deleted in Mitf(ce). This interaction is necessary for the phosphorylation of MITF by p38 MAPK. Site-directed mutations in the docking site interfered with the interaction between MITF and its co-factors FUS and BRG1. MITF-ce fails to recruit FUS and BRG1 to target genes, resulting in decreased expression of target genes and impaired osteoclast function. These results highlight the crucial role of signaling dependent MITF/p38 MAPK interactions in osteoclast differentiation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26218069      PMCID: PMC4664053          DOI: 10.1002/jcp.25108

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.

Authors:  T J Hemesath; E Steingrímsson; G McGill; M J Hansen; J Vaught; C A Hodgkinson; H Arnheiter; N G Copeland; N A Jenkins; D E Fisher
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

4.  Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling.

Authors:  Kim C Mansky; Uma Sankar; Jiahuai Han; Michael C Ostrowski
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

5.  Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.

Authors:  A Luchin; S Suchting; T Merson; T J Rosol; D A Hume; A I Cassady; M C Ostrowski
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

6.  Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding.

Authors:  Ying H Shen; Jakub Godlewski; Agnieszka Bronisz; Jun Zhu; Michael J Comb; Joseph Avruch; Guri Tzivion
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

7.  Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.

Authors:  Sudarshana M Sharma; Said Sif; Michael C Ostrowski; Uma Sankar
Journal:  J Cell Physiol       Date:  2009-07       Impact factor: 6.384

Review 8.  Insight into the microphthalmia gene.

Authors:  K J Moore
Journal:  Trends Genet       Date:  1995-11       Impact factor: 11.639

9.  Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3.

Authors:  K N Weilbaecher; C L Hershey; C M Takemoto; M A Horstmann; T J Hemesath; A H Tashjian; D E Fisher
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

Review 10.  Factors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts.

Authors:  Kyoji Ikeda; Sunao Takeshita
Journal:  J Bone Metab       Date:  2014-08-31
View more
  4 in total

Review 1.  The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia.

Authors:  Zhipeng Qi; Jiashuo Li; Minghui Li; Xianchao Du; Lei Zhang; Shuang Wang; Bin Xu; Wei Liu; Zhaofa Xu; Yu Deng
Journal:  Cell Mol Neurobiol       Date:  2021-08-12       Impact factor: 4.231

Review 2.  The endocytic pathway in microglia during health, aging and Alzheimer's disease.

Authors:  Santiago Solé-Domènech; Dana L Cruz; Estibaliz Capetillo-Zarate; Frederick R Maxfield
Journal:  Ageing Res Rev       Date:  2016-07-12       Impact factor: 10.895

3.  Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival.

Authors:  Jennifer Ferguson; Daniel J Wilcock; Sophie McEntegart; Andrew P Badrock; Mitch Levesque; Reinhard Dummer; Claudia Wellbrock; Michael P Smith
Journal:  Pigment Cell Melanoma Res       Date:  2019-08-08       Impact factor: 4.693

4.  Enhancer variants reveal a conserved transcription factor network governed by PU.1 during osteoclast differentiation.

Authors:  Heather A Carey; Blake E Hildreth; Jennifer A Geisler; Mara C Nickel; Jennifer Cabrera; Sankha Ghosh; Yue Jiang; Jing Yan; James Lee; Sandeep Makam; Nicholas A Young; Giancarlo R Valiente; Wael N Jarjour; Kun Huang; Thomas J Rosol; Ramiro E Toribio; Julia F Charles; Michael C Ostrowski; Sudarshana M Sharma
Journal:  Bone Res       Date:  2018-03-28       Impact factor: 13.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.